论文部分内容阅读
目的了解清远市清新区2008—2011年法定报告传染病流行特征,为制定相应的防治对策提供科学依据。方法采用描述性流行病学方法对清远市清新区2008—2011年法定报告传染病疫情资料进行分析。结果 2008—2011年共报告法定传染病23种16 060例,年平均发病率为672.40/10万;报告的乙、丙类传染病以肠道传染病为主,占发病总数的60.50%(9 716例);其次为呼吸道传染病,占发病总数的25.54%(4 101例);血源及性传播传染病占发病总数的13.52%(2 172例);自然疫源及虫媒传染病占发病总数的0.44%(71例)。报告发病率居前5位的依次为手足口病(6 063例)、其他感染性腹泻(3 103例)、肺结核(2 855例)、梅毒(1 108例)、流行性腮腺炎(877例),年平均发病率分别为253.85/10万、129.92/10万、119.53/10万、46.39/10万、36.72/10万。结论手足口病、其他感染性腹泻病、肺结核、梅毒和流行性腮腺炎是清新区近年需重点防控的传染病,今后应重点加强对肠道传染病、呼吸道传染病的监测和防治。
Objective To understand the epidemiological characteristics of legal notifiable infectious diseases in Qingyuan District of Qingyuan City from 2008 to 2011 and provide a scientific basis for formulating corresponding prevention and control measures. Methods Descriptive epidemiological methods were used to analyze the statutory reported infectious diseases in Qingyuan District of Qingyuan City from 2008 to 2011. Results A total of 16 060 cases of legal infectious diseases were reported from 2008 to 2011, with an average annual incidence of 672.40 / 100 000. The reported cases of infectious diseases of categories B and C were mainly intestinal infectious diseases, accounting for 60.50% of the total 716 cases), followed by respiratory diseases (25.54% (4 101 cases)), blood and sexually transmitted diseases accounted for 13.52% (2 172 cases), natural foci and zoonosis accounted for The incidence of 0.44% of the total (71 cases). The top five reported cases were hand-foot-mouth disease (6 063 cases), other infectious diarrhea (3 of 103), tuberculosis (2 855 cases), syphilis (1 108 cases), mumps (877 cases ), The average annual incidence was 253.85 / 100000, 129.92 / 100000, 119.53 / 100000, 46.39 / 100000, 36.72 / 100000. Conclusion Hand, foot and mouth disease, other infectious diarrhea, tuberculosis, syphilis and mumps are the most important infectious diseases that need to be prevented and controlled in recent years in the fresh area. In the future, we should focus on monitoring and prevention of intestinal infectious diseases and respiratory infectious diseases.